CZ282723B6 - 2-Substituované chinoliny, způsob jejich přípravy a jejich použití v léčivech - Google Patents

2-Substituované chinoliny, způsob jejich přípravy a jejich použití v léčivech Download PDF

Info

Publication number
CZ282723B6
CZ282723B6 CS92514A CS51492A CZ282723B6 CZ 282723 B6 CZ282723 B6 CZ 282723B6 CS 92514 A CS92514 A CS 92514A CS 51492 A CS51492 A CS 51492A CZ 282723 B6 CZ282723 B6 CZ 282723B6
Authority
CZ
Czechia
Prior art keywords
carbon atoms
straight
formula
branched
hydrogen
Prior art date
Application number
CS92514A
Other languages
Czech (cs)
English (en)
Inventor
Siegfried Dr. Raddatz
Klaus-Helmut Dr. Mohrs
Michael Dr. Matzke
Romanis Fruchtmann
Armin Dr. Hatzelmann
Christian Dr. Kohlsdorfer
Reiner Prof. Dr. Müller-Peddinghaus
Pia Dr. Theisen-Popp
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of CS51492A3 publication Critical patent/CS51492A3/cs
Publication of CZ282723B6 publication Critical patent/CZ282723B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Earth Drilling (AREA)
CS92514A 1991-02-22 1992-02-21 2-Substituované chinoliny, způsob jejich přípravy a jejich použití v léčivech CZ282723B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105551A DE4105551A1 (de) 1991-02-22 1991-02-22 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
CS51492A3 CS51492A3 (en) 1992-12-16
CZ282723B6 true CZ282723B6 (cs) 1997-09-17

Family

ID=6425643

Family Applications (1)

Application Number Title Priority Date Filing Date
CS92514A CZ282723B6 (cs) 1991-02-22 1992-02-21 2-Substituované chinoliny, způsob jejich přípravy a jejich použití v léčivech

Country Status (20)

Country Link
EP (1) EP0499926B1 (enExample)
JP (1) JPH0592957A (enExample)
KR (1) KR920016424A (enExample)
AT (1) ATE142623T1 (enExample)
AU (1) AU641585B2 (enExample)
CZ (1) CZ282723B6 (enExample)
DE (2) DE4105551A1 (enExample)
DK (1) DK0499926T3 (enExample)
ES (1) ES2091958T3 (enExample)
FI (1) FI920732L (enExample)
GR (1) GR3021014T3 (enExample)
HU (1) HUT67037A (enExample)
IE (1) IE75728B1 (enExample)
IL (1) IL101009A (enExample)
MY (1) MY108459A (enExample)
NZ (1) NZ241654A (enExample)
PL (2) PL171026B1 (enExample)
RU (1) RU2077532C1 (enExample)
TW (1) TW200463B (enExample)
ZA (1) ZA921268B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
TW232013B (enExample) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4301900A1 (de) * 1993-01-25 1994-07-28 Bayer Ag 2-Oxochinolin-1-yl-methylphenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
ATE188377T1 (de) * 1993-06-29 2000-01-15 Takeda Chemical Industries Ltd Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
ES2226377T3 (es) * 1998-05-11 2005-03-16 Takeda Chemical Industries, Ltd. Derivados de acido oxiimino-alcalino con actividad hipoglucemica e hipolipidemica.
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
HRP20010795A2 (en) * 1999-04-28 2003-02-28 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands
RU2177317C1 (ru) * 2000-10-24 2001-12-27 Московский научно-исследовательский институт медицинской экологии (МНИИМЭ) Производные хинолина для коррекции системы гемостаза, фармацевтическая композиция, средство для коррекции гемостаза
TWI309644B (enExample) * 2001-02-14 2009-05-11 Nissan Chemical Ind Ltd
US6867320B2 (en) 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
JP2007516258A (ja) 2003-12-12 2007-06-21 ワイス 心臓血管の疾患治療に有用なキノリン誘導体
BRPI0518222A (pt) * 2004-10-19 2008-11-04 Hoffmann La Roche composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos
CN101611029B (zh) * 2006-12-21 2014-09-10 辉瑞产品公司 2-((4-(1-甲基-4-(吡啶-4-基)-1h-吡唑-3-基)苯氧基)甲基)喹啉的琥珀酸盐

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3908298A1 (de) * 1989-03-14 1990-09-20 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-n,n'-sulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
RU2077532C1 (ru) 1997-04-20
AU1054292A (en) 1992-08-27
DE4105551A1 (de) 1992-08-27
NZ241654A (en) 1994-11-25
IL101009A0 (en) 1992-11-15
EP0499926B1 (de) 1996-09-11
ATE142623T1 (de) 1996-09-15
MY108459A (en) 1996-09-30
ES2091958T3 (es) 1996-11-16
JPH0592957A (ja) 1993-04-16
IE75728B1 (en) 1997-09-24
HU9200582D0 (en) 1992-05-28
FI920732A7 (fi) 1992-08-23
FI920732L (fi) 1992-08-23
EP0499926A1 (de) 1992-08-26
IL101009A (en) 1996-08-04
PL293534A1 (en) 1992-10-05
GR3021014T3 (en) 1996-12-31
DE59207074D1 (de) 1996-10-17
PL170726B1 (pl) 1997-01-31
DK0499926T3 (enExample) 1997-02-10
ZA921268B (en) 1992-11-25
KR920016424A (ko) 1992-09-24
IE920557A1 (en) 1992-08-26
PL171026B1 (pl) 1997-02-28
CS51492A3 (en) 1992-12-16
FI920732A0 (fi) 1992-02-20
AU641585B2 (en) 1993-09-23
HUT67037A (en) 1995-01-30
TW200463B (enExample) 1993-02-21

Similar Documents

Publication Publication Date Title
AU641585B2 (en) 2-substituted quinolines, process for their preparation and their use in medicaments
KR100210214B1 (ko) 치환 (퀴놀린-2-일-메톡시)페닐-아실-술폰아미드-및-시안아미드, 그의 제조방법 및 약제로서의 용도
US5192771A (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
US20100120839A1 (en) Pyrazoles useful in the treatment of inflammation
JPH0390062A (ja) 置換n―(キノリン―2―イル―メトキシ)ベンジルスルホニルウレア
US5266578A (en) Heterocyclically substituted quinolylmethoxy-phenylacetamides
SK86593A3 (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
CZ390392A3 (en) Benzofuranyl- and thiophenylmethylthio alkanecarboxylic acid derivatives, process of their preparation and use
US5045547A (en) Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use thereas
CN103012381A (zh) 苯基呋喃类化合物、其制备方法及在制备抗心律失常药物中的应用
JPH062744B2 (ja) 3−アミノカルボニルメトキシ−5−フエニルピラゾ−ル化合物、その製法、およびこれを含有する抗不整脈作用を有する薬剤
US5310744A (en) Quinolylmethoxyphenyl-acetamides
OA10944A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
CZ233692A3 (en) Quinolin-2-yl-methoxybenzyl hydroxyureas
US5304563A (en) 2-substituted quinolines, and their use in medicaments
SK62293A3 (en) Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives
CZ163693A3 (en) Novel isobutyl substituted amides of methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid
US5120744A (en) Substituted (quinolin-2-yl-methoxy)phenylthioureas
CZ355992A3 (en) Acyl amides and ureas of quinolylmethoxyphenylacetic acid
WO2008135767A1 (en) New triazole compounds useful in the treatment of inflammation
CZ355892A3 (cs) Thiazolyl-substituované deriváty kyseliny chino lyimethoxyfenyloctové